Identification of the gene for vitamin K epoxide reductase

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Nature

• Publication date

  2004-02-05

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nature02254PMID 14765195
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin K-dependent proteins in the developing and aging nervous system.

  2009cited by this paper
• Increased genome instability in aging yeast.

  2003cited by this paper
• Functional siRNAs and miRNAs exhibit strand bias.

  2003cited by this paper
• Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway.

  2003cited by this paper
• Expression profiling reveals off-target gene regulation by RNAi

  2003cited by this paper
• Silencing of the Novel p53 Target Gene Snk/Plk2 Leads to Mitotic Catastrophe in Paclitaxel (Taxol)-Exposed Cells

  2003cited by this paper
• The Vitamin K-dependent Carboxylase

  2002cited by this paper
• Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action.

  2002cited by this paper
• Single-stranded antisense siRNAs guide target RNA cleavage in RNAi.

  2002cited by this paper
• Homozygosity mapping of a second gene locus for hereditary combined deficiency of vitamin K-dependent clotting factors to the centromeric region of chromosome 16.

  2002cited by this paper
• The Putative Vitamin K-dependent γ-Glutamyl Carboxylase Internal Propeptide Appears to Be the Propeptide Binding Site*

  2002cited by this paper
• RNAi functions in cultured mammalian neurons

  2002cited by this paper
• Identification of two novel transmembrane gamma-carboxyglutamic acid proteins expressed broadly in fetal and adult tissues.

  2001cited by this paper
• Identification of essential genes in cultured mammalian cells using small interfering RNAs.

  2001cited by this paper
• Identification of a Drosophila Vitamin K-dependent γ-Glutamyl Carboxylase*

  2000cited by this paper
• Advanced 5'-silyl-2'-orthoester approach to RNA oligonucleotide synthesis.

  2000cited by this paper
• A gene-anchored map position of the rat warfarin-resistance locus, Rw, and its orthologs in mice and humans.

  2000cited by this paper
• Identification of a Drosophila vitamin K-dependent gamma-glutamyl carboxylase.

  2000cited by this paper
• The vitamin K-dependent carboxylase.

  2000cited by this paper
• Warfarin therapy: evolving strategies in anticoagulation.

  1999cited by this paper
• Primary structure and tissue distribution of two novel proline-rich gamma-carboxyglutamic acid proteins.

  1997cited by this paper
• Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

  1997cited by this paper
• Surface hydrophobicity and intracellular degradation of proteins.

  1996cited by this paper
• The Major Calpain Isozymes Are Long-lived Proteins

  1996cited by this paper
• Microsomal lipoamide reductase provides vitamin K epoxide reductase with reducing equivalents.

  1994cited by this paper
• The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade

  1993cited by this paper
• The warfarin embryopathy: a rat model showing maxillonasal hypoplasia and other skeletal disturbances.

  1992cited by this paper
• Cloning and expression of the cDNA for human gamma-glutamyl carboxylase.

  1991cited by this paper
• Vitamin K dependent carboxylase: subcellular location of the carboxylase and enzymes involved in vitamin K metabolism in rat liver.

  1980cited by this paper
• Hazards of oral anticoagulants during pregnancy.

  1980cited by this paper
• Warfarin-associated embryopathy in a 17-week-old abortus.

  1976cited by this paper
• Relationship between in vivo degradative rates and isoelectric points of proteins.

  1975cited by this paper
• Biochemical basis of hereditary resistance to warfarin in the rat.

  1974cited by this paper

• VKORC1L1 Downregulation Induced Vitamin K Cycle Disorder Exacerbates Neuronal Ferroptosis After Spinal Cord Injury

  2026cites this paper
• Interspecies variability in hepatic vitamin K reserves - implications for anticoagulant rodenticide sensitivity and ecotoxicological risk assessment.

  2025cites this paper
• Enhancing clinical research with pharmacogenomics: a practical perspective.

  2025cites this paper
• Rapid population expansion drives the widespread spread of a dominant anticoagulant-resistance Vkorc1 allele in Asian house rats (Rattus tanezumi) across China.

  2025cites this paper
• Structure and mechanism of vitamin-K-dependent γ-glutamyl carboxylase

  2025cites this paper
• VKORC1 polymorphisms and complete resistance to vitamin K antagonists: About two cases

  2024cites this paper
• Adaptation in the Alleyways: Candidate Genes Under Potential Selection in Urban Coyotes

  2024cites this paper
• Vitamin K-dependent carboxylation in β-cells and diabetes.

  2024cites this paper
• Warfarin analogs target disulfide bond-forming enzymes and suggest a residue important for quinone and coumarin binding

  2024cites this paper
• Investigation of warfarin overdose and related factors in the emergency department

  2024cites this paper
• β,γ-Methylene-ATP and its metabolite medronic acid affect both arterial media calcification and bone mineralization in non-CKD and CKD rats

  2024cites this paper
• A functional genomic framework to elucidate novel causal non-alcoholic fatty liver disease genes

  2024cites this paper
• A functional genomic framework to elucidate novel causal metabolic dysfunction–associated fatty liver disease genes

  2024cites this paper
• A physiologically‐based pharmacokinetic/pharmacodynamic modeling approach for drug–drug‐gene interaction evaluation of S‐warfarin with fluconazole

  2024cites this paper
• Clinical, Laboratory, and Molecular Characteristics of Inherited Vitamin K–Dependent Coagulation Factors Deficiency

  2024cites this paper
• Antivitamines K : pharmacologie et pharmacogénétique

  2024cites this paper
• Genomic Innovation in Early Life Cardiovascular Disease Prevention and Treatment

  2023cites this paper
• Diverse biological functions of vitamin K: from coagulation to ferroptosis

  2023cites this paper
• Multi-omics characteristics of tumor-associated macrophages in the tumor microenvironment of gastric cancer and their exploration of immunotherapy potential

  2023cites this paper
• VKORC1-based resistance to anticoagulant rodenticides widespread in Finnish house mice but not in brown rats

  2023cites this paper
• Exposure and resistance to anticoagulant rodenticides in invasive and endemic Chadian urban rodent species to develop a rational management strategy.

  2023cites this paper
• TAM receptors in phagocytosis: Beyond the mere internalization of particles

  2023cites this paper
• Design of a structure-activity relationship model of vitamin K epoxide reductase (VKORC1) inhibitors combining chemical synthesis of new compounds, enzymatic assays and molecular modelling.

  2023cites this paper
• Vitamin K: history, metabolism, and nutrition in the horse

  2023cites this paper
• A genome-wide CRISPR-Cas9 knockout screen identifies FSP1 as the warfarin-resistant vitamin K reductase

  2023cites this paper
• Application of Pharmacogenetics for the Use of Antiplatelet and Anticoagulant Drugs

  2023cites this paper
• Widespread distribution of rodenticide resistance-conferring mutations in the Vkorc1 gene among house mouse populations in Portuguese Macaronesian islands and Iberian Atlantic areas.

  2023cites this paper
• In silico evaluation of pharmacokinetic parameters, delivery, distribution and anticoagulative effects of new 4,7-dihydroxycoumarin derivative

  2023cites this paper
• Distinct enzymatic strategies for de novo generation of disulfide bonds in membranes

  2023cites this paper
• Allelic Variants in the Warfarin-related Genes VKORC1 and CYP2C9 in a Western Saudi Population

  2023cites this paper
• The prevalence of pharmacogenetic variants of vitamin K epoxide reductase complex subunit 1 gene (rs9923231), cytochrome P450 family 2 subfamily C member 9 gene (rs1799853) and cytochrome P450 family 3 subfamily-A member-5 gene (rs776746) among 13 ethnic groups of Pakistan

  2023cites this paper
• INVESTIGATING THE GENETIC EFFECT OF VKORC1 GENE POLYMORPHISM ON WARFARIN RESPONSE IN EGYPTIAN HEART PATIENTS

  2023influential citation
• Prediction of Drug-induced Mitochondrial Dysfunction Using Succinate-cytochrome c Reductase Activity, QSAR and Molecular Docking.

  2022cites this paper
• Large‐scale identification of rodenticide resistance in Rattus norvegicus and Mus musculus in the Netherlands based on Vkorc1 codon 139 mutations

  2022cites this paper
• Low Level of Resistance to Anticoagulant Rodenticides in the Vkorс1 Gene in House Mice (Mus musculus) and Norway Rats (Rattus norvegicus) in Russia

  2022cites this paper
• Biochemistry of Anticoagulant Drugs: A molecular approach

  2022cites this paper
• The screening for anticoagulant rodenticide gene VKORC1 polymorphism in the rat Rattus norvegicus, Rattus tanezumi and Rattus losea in Hong Kong

  2022cites this paper
• Apparent resistance to brodifacoum in Rattus rattus in a New Zealand site with no history of anticoagulant-based rodent control

  2022cites this paper
• Overexpression of protein disulfide isomerase enhances vitamin K epoxide reductase activity.

  2022cites this paper
• Structural and cellular basis of vitamin K antagonism

  2022cites this paper
• GGCX mutants that impair hemostasis reveal the importance of processivity and full carboxylation to VKD protein function.

  2022cites this paper
• Sanitary measures considerably improve the management of resistant Norway rats on livestock farms.

  2022cites this paper
• Clinical pharmacogenetics

  2022cites this paper
• Distribution of non-synonymous Vkorc1 mutations in roof rats (Rattus rattus) in France and in Spain - consequences for management.

  2022cites this paper
• Prevalence of anticoagulant rodenticide resistance in two commensal rodent species in Finland

  2021cites this paper
• Vitamin K in human health and metabolism: A nutri-genomics review

  2021cites this paper
• The Curious Case of Aqueous Warfarin: Structural Isomers or Distinct Excited States?

  2021cites this paper
• Gut Microbiota and the Quality of Oral Anticoagulation in Vitamin K Antagonists Users: A Review of Potential Implications

  2021cites this paper
• Measuring Pharmacogene Variant Function at Scale Using Multiplexed Assays.

  2021cites this paper
• Pharmacogenomics: Overview, Applications, and Recent Developments

  2020cites this paper
• Post-translational modifications of the ligands: Requirement for TAM receptor activation.

  2020cites this paper
• The catalytic mechanism of vitamin K epoxide reduction in a cellular environment

  2020cites this paper
• A Vkorc1-Based Snp Survey of Anticoagulant Rodenticide Resistance in The House Mouse, Norway Rat, and Roof Rat in The Usa.

  2020cites this paper
• Effects of rare CYP2C9 alleles on stable warfarin doses in Chinese Han patients with atrial fibrillation.

  2020cites this paper
• Genetic polymorphisms associated with upper gastrointestinal bleeding: a systematic review

  2020cites this paper
• Sublethal dose of warfarin induction promotes the accumulation of warfarin resistance in susceptible Norway rats

  2020cites this paper
• Influence of genotype on warfarin dose requirements-a systematic review and meta-analysis

  2020cites this paper
• Real-time and label-free detection of VKORC1 genes based on a magnetoelastic biosensor for warfarin therapy.

  2020cites this paper
• –1639G>A and are the major genetic predictors of phenprocoumon dose requirement

  2020cites this paper
• Competitive tight-binding inhibition of VKORC1 underlies warfarin dosage variation and antidotal efficacy.

  2020cites this paper
• Multiplexed measurement of variant abundance and activity reveals VKOR topology, active site and human variant impact

  2020cites this paper
• Pharmacological TNAP inhibition efficiently inhibits arterial media calcification in a warfarin rat model but deserves careful consideration of potential physiological bone formation/mineralization impairment.

  2020cites this paper
• Characterization of Warfarin Inhibition Kinetics Requires Stabilization of Intramembrane Vitamin K Epoxide Reductases.

  2020cites this paper
• Pharmacological and Therapeutic Aspects of Plants from the Genus Ferula: a Comprehensive Review.

  2020cites this paper
• VKORC1 Gene

  2020cites this paper
• Screening and prevention of anticoagulant resistance development in house mice: A review

  2020cites this paper
• Chiral voltammetric sensor for warfarin enantiomers based on carbon black paste electrode modified by 3,4,9,10-perylenetetracarboxylic acid

  2020cites this paper
• Genome-wide analyses disclose the distinctive HLA architecture and the pharmacogenetic landscape of the Somali population

  2020cites this paper
• Rat models of human diseases and related phenotypes: a systematic inventory of the causative genes

  2020cites this paper
• Structural investigation of vitamin K epoxide reductase (VKORC1) binding site with vitamin K.

  2020cites this paper
• VKORC 1 inhibitors binds VKORC 1 dimer ↗

  2020cites this paper
• Comparison of two reducing agents dithiothreitol and tris(3-hydroxypropyl)phosphine for in vitro kinetic assay of vitamin K epoxide reductase

  2020cites this paper
• Vitamin K antagonist rodenticides display different teratogenic activity.

  2020cites this paper
• Pharmacogenomics and personalized medicine in the treatment of human diseases

  2020cites this paper
• A novel vitamin K derived anticoagulant tolerant to genetic variations of vitamin K epoxide reductase

  2020cites this paper
• Susceptibility of house mouse carriers of Tyr139Cys and Leu128Ser/Tyr139Cys VKOR variants to difenacoum

  2020cites this paper
• Association between VKORC1 gene polymorphism and warfarin dose requirement and frequency of VKORC1 gene polymorphism in patients from Kerman province

  2020cites this paper
• Accidental chlorophacinone exposure of lactating ewes: Clinical follow-up and human health dietary implications.

  2020cites this paper
• Effects of CYP2C9 and VKORC1 polymorphisms on warfarin sensitivity and responsiveness during the stabilization phase of therapy

  2019cites this paper
• Oral Anticoagulant Therapy—When Art Meets Science

  2019cites this paper
• Insights into the ubiquinol/dioxygen binding and proton relay pathways of the alternative oxidase.

  2019cites this paper
• Pharmacology of Oral Anticoagulants

  2019cites this paper
• Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fibrillation using warfarin

  2019cites this paper
• Bridging the Gaps in Personalized Medicine Value Assessment: A Review of the Need for Outcome Metrics across Stakeholders and Scientific Disciplines

  2019cites this paper
• Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP 2 C 9 and VKORC 1 in Brazilian subjects

  2019cites this paper
• Outpatient Oral Anticoagulant Therapy

  2019cites this paper
• The potential of VKORC1 polymorphisms in Mustelidae for evolving anticoagulant resistance through selection along the food chain

  2019cites this paper
• First record of VKORC1 sequence mutation associated with resistance to anticoagulant rodenticides in Italian individuals of Mus musculus domesticus

  2019cites this paper
• PGPM_A_187350 47..57

  2019cites this paper
• Compound heterozygosity of the gamma-glutamyl carboxylase mutants V255M and S300F causes pseudoxanthoma elasticum-like disease through impaired processivity

  2019cites this paper
• Efficacy and Safety of Genotype-Guided Warfarin Dosing in the Chinese Population: A Meta-analysis of Randomized Controlled Trials

  2019cites this paper
• Structural Insights into Phylloquinone (Vitamin K1), Menaquinone (MK4, MK7), and Menadione (Vitamin K3) Binding to VKORC1

  2019cites this paper
• Determining the necessity of phenyl ring π-character in warfarin.

  2019cites this paper
• Redox-Mediated Quantum Dots as Fluorescence Probe and Their Biological Application

  2019cites this paper
• VKORC1 variants as significant predictors of warfarin dose in Emiratis

  2019cites this paper
• The Impact of CYP2C9 and VKORC1 Polymorphism in Patient’s Response to Warfarin and Acenocoumarol

  2019cites this paper
• Functional divergence and natural selection underlying genome wide introgressive hybridization of protein coding genes between the Algerian mouse (Mus spretus) and the house mouse (Mus musculus domesticus)

  2019cites this paper
• Polymorphisms of CYP2C9*2, CYP2C9*3 and VKORC1 genes related to time in therapeutic range in patients with atrial fi brillation using warfarin

  2019cites this paper
• A statistical framework for cross-tissue transcriptome-wide 1 association analysis 2 3 4

  2019cites this paper
• Algorithm for predicting low maintenance doses of warfarin using age and polymorphisms in genes CYP2C9 and VKORC1 in Brazilian subjects

  2019cites this paper